BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 21838139)

  • 1. [Effects of health-service reform in the field of medicinal drugs II. Analysis from the standpoint of financial participation of the patient in pharmacotherapy].
    Macesková B; Koska M
    Ceska Slov Farm; 2011 Jun; 60(3):105-9. PubMed ID: 21838139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of health-service reform in the field of medicinal drugs I. Analysis from the standpoint of a pharmacy].
    Macesková B; Streitová J
    Ceska Slov Farm; 2011 Jun; 60(3):99-104. PubMed ID: 21838138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation in pharmaceutical costs and seniors' access to medicines in the Czech Republic.
    Davidová J; Ivanovic N; Práznovcová L
    Cent Eur J Public Health; 2008 Mar; 16(1):26-8. PubMed ID: 18459476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of self-measurement of blood glucose on complications of type 2 diabetes: economic analysis from a Czech perspective.
    Weber C; Kocher S; Neeser K; Bartaskova D
    Curr Med Res Opin; 2010 Feb; 26(2):289-96. PubMed ID: 19947908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reform of the health care service system in Israel 1995-2000.
    Hart J
    World Hosp Health Serv; 2001; 37(3):9-11, 40, 42. PubMed ID: 11858011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary care and prescription drugs: coverage, cost-sharing, and financial protection in six European countries.
    Thomson S; Mossialos E
    Issue Brief (Commonw Fund); 2010 Mar; 82():1-14. PubMed ID: 20411629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Croatian pharmaceutical sector reform project: rational drug use.
    Harvey K; Kalanj K; Stevanović R
    Croat Med J; 2004 Oct; 45(5):611-9. PubMed ID: 15495290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.
    Li X; Guh D; Lacaille D; Esdaile J; Anis AH
    Health Policy; 2007 Aug; 82(3):340-7. PubMed ID: 17134787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of anti-epileptic drugs in fee-for-service Wisconsin Medicaid.
    Mergener MA; Carr RM
    WMJ; 2006 Sep; 105(6):36-9. PubMed ID: 17042418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' health in contract and fee-for-service care. I. A descriptive comparison.
    Johansson V; Axtelius B; Söderfeldt B; Sampogna F; Paulander J; Sondell K
    Swed Dent J; 2007; 31(1):27-34. PubMed ID: 17508707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Draft Clinton health reform proposal is circulated as alternatives surface.
    Wash Memo Alan Guttmacher Inst; 1993 Sep; (14):1-2. PubMed ID: 12318381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care.
    Piette JD; Wagner TH; Potter MB; Schillinger D
    Med Care; 2004 Feb; 42(2):102-9. PubMed ID: 14734946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abolition of prescription charges in Wales: the impact on medicines use in those who used to pay.
    Groves S; Cohen D; Alam MF; Dunstan FD; Routledge PA; Hughes DA; Myles S
    Int J Pharm Pract; 2010 Dec; 18(6):332-40. PubMed ID: 21054593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.
    Soumerai SB; Avorn J; Ross-Degnan D; Gortmaker S
    N Engl J Med; 1987 Aug; 317(9):550-6. PubMed ID: 3302713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nine months German Statutory Health Insurance Structural Reform Law--effects and perspectives].
    Engel H
    Gesundheitswesen; 1994 Feb; 56(2):76-9. PubMed ID: 8148595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of urban health insurance reform on hospital charges: a case study from two cities in China.
    Meng Q; Rehnberg C; Zhuang N; Bian Y; Tomson G; Tang S
    Health Policy; 2004 May; 68(2):197-209. PubMed ID: 15063019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.